跳至主要内容
临床试验/NCT07815964
NCT07815964尚未招募不适用

Turkish Validity and Reliability of the Parkinson's Disease Neuropsychometric Dementia Assessment Questionnaire in Individuals With Parkinson's Disease

Acibadem University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Parkinson Neuropsychometric Dementia Assessment (PANDA) Total Score

研究概览

简要总结

The aim of this study is to examine the validity and reliability of the Turkish version of the Parkinson's Neuropsychometric Dementia Assessment (PANDA) in individuals with Parkinson's disease. This cross-sectional methodological study will evaluate the psychometric properties of the Turkish PANDA, including internal consistency, test-retest reliability, and construct validity, in order to provide a valid and reliable instrument for the assessment of cognitive impairment and dementia-related cognitive changes in Turkish-speaking individuals with Parkinson's disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • **Inclusion Criteria:**
  • Clinical diagnosis of Parkinson's disease
  • Hoehn and Yahr stage 1-3
  • Age between 40 and 85 years
  • Mini-Mental State Examination score ≥ 24
  • Sufficient cognitive and communication ability to complete the assessments
  • Attendance at the Movement Disorders Outpatient Clinic of the Neurology Department
  • Willingness to participate in the study and provide written informed consent

排除标准

  • Presence of a major psychiatric disorder, such as major depressive disorder or a psychotic disorder
  • Diagnosis of advanced dementia
  • Presence of an uncontrolled systemic chronic disease, such as uncontrolled diabetes mellitus or hypertension
  • Presence of a severe cardiovascular or respiratory condition
  • Presence of an additional orthopedic or neurological condition that may affect assessment performance
  • Severe visual or hearing impairment that may interfere with the assessments
  • Inability to cooperate adequately during the assessments

研究组 & 干预措施

Parkinson's Disease

干预措施: Parkinson Neuropsychometric Dementia Assessment (Other)

结局指标

主要结局

Parkinson Neuropsychometric Dementia Assessment (PANDA) Total Score

时间窗: [Time Frame: Baseline (at the time of PANDA administration)]

Cognitive performance will be assessed using the Turkish version of the Parkinson's Neuropsychometric Dementia Assessment (PANDA) in individuals with Parkinson's disease. The PANDA is a brief cognitive screening instrument specifically developed for Parkinson's disease and includes tasks assessing learning and memory, verbal fluency, visuospatial processing, working memory, and delayed recall. The PANDA total score ranges from 0 to 30, with higher scores indicating better cognitive performance. The psychometric properties of the Turkish version, including internal consistency, test-retest reliability, and construct validity, will be evaluated.

次要结局

  • Montreal Cognitive Assessment (MoCA) Total Score([Time Frame: Baseline (at the time of cognitive assessment)])
  • Mini-Mental State Examination (MMSE) Total Score([Time Frame: Baseline (at the time of cognitive assessment)])

研究者

发起方
Acibadem University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nuray Alaca

Prof. Dr

Acibadem University

研究点 (1)

Loading locations...

相似试验